Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (561-570 of 706) with videos related to

Pageof 71
Sort By:
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|December 24, 2019
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary SyndromesAmy A Sarma, Eugene Braunwald, Christopher P Cannon, et al.
Journal of Clinical Lipidology|March 21, 2020
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|May 25, 2005
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain CentersW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
Annals of Emergency Medicine|July 28, 2005
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency departmentW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
JAMA Network Open|April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an AnticoagulantChristopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Circulation|October 7, 2020
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, David Z I Cherney, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Pageof 71

Showing results (561-570 of 706) with videos related to

Sort By:
Pageof 71
Journal of Clinical Lipidology|December 22, 2015
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|November 9, 2005
Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) RegistryJason W Ryan, Eric D Peterson, Anita Y Chen, et al.
Journal of the American College of Cardiology|December 24, 2019
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary SyndromesAmy A Sarma, Eugene Braunwald, Christopher P Cannon, et al.
Journal of Clinical Lipidology|March 21, 2020
Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trialPatrick M Moriarty, Paul D Thompson, Christopher P Cannon, et al.
Circulation|May 25, 2005
Practical implementation of the guidelines for unstable angina/non-ST-segment elevation myocardial infarction in the emergency department: a scientific statement from the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain CentersW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
Annals of Emergency Medicine|July 28, 2005
Practical implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the emergency departmentW Brian Gibler, Christopher P Cannon, Andra L Blomkalns, et al.
JAMA Network Open|April 24, 2023
Patients and Their Physician's Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an AnticoagulantChristopher P Cannon, Joseph M Kim, Jane J Lee, et al.
Circulation|October 7, 2020
Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV TrialFrancesco Cosentino, Christopher P Cannon, David Z I Cherney, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
American Heart Journal|April 8, 2003
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 studyGad Cotter, Christopher P Cannon, Carolyn H McCabe, et al.
Pageof 71